title: [Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?].
authors.forename: M
authors.initials: M
authors.lastname: Doffoël
authors.forename: D
authors.initials: D
authors.lastname: Vetter
mesh_terms: D000208:Acute Disease; D004359:Drug Therapy, Combination; D006471:Gastrointestinal Hemorrhage / Q000150:complications*; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008353:Mannitol / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use*; D007507:Therapeutic Irrigation
chemical_list: D008353:Mannitol; D007792:Lactulose; D009355:Neomycin
vernacular_title: Le traitement "spécifique" de l'encéphalopathie hépatique aiguë est-il justifié au cours de la cirrhose?